Drug interactions for the following drug(s)
Applies to: Lovastatin 40 MG Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
The serum concentration of Metoprolol can be increased when it is combined with Lovastatin.
Applies to: sucralfate 1 GM Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluticasone propionate.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Losartan K+ 25 MG Oral Tablet
The metabolism of Acetylsalicylic acid can be decreased when combined with Losartan.
Applies to: Lovastatin 40 MG Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
The metabolism of Levothyroxine can be decreased when combined with Lovastatin.
Applies to: Lovastatin 40 MG Oral Tablet <> Ranitidine 150 MG Oral Tablet
The serum concentration of Lovastatin can be increased when it is combined with Ranitidine.
Applies to: Ranitidine 150 MG Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
The serum concentration of Metoprolol can be increased when it is combined with Ranitidine.
Applies to: Lovastatin 40 MG Oral Tablet <> Losartan K+ 25 MG Oral Tablet
The serum concentration of Lovastatin can be increased when it is combined with Losartan.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Applies to: Lovastatin 40 MG Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
The metabolism of Fluticasone furoate can be decreased when combined with Lovastatin.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Losartan K+ 25 MG Oral Tablet
Metoprolol may increase the hypotensive activities of Losartan.
Applies to: Lovastatin 40 MG Oral Tablet <> aspirin 81 MG Enteric Coated Oral Tablet
The metabolism of Acetylsalicylic acid can be decreased when combined with Lovastatin.
Applies to: Methocarbamol 500 MG Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fluticasone propionate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Lovastatin 40 MG Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Lovastatin, Drug2 is resolved to Metoprolol and interaction asserted in DrugBank between Lovastatin and Metoprolol.
Applies to: sucralfate 1 GM Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
Drug1 (rxcui = 314234, name = Sucralfate 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = Levothyroxine Sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to Sucralfate, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Sucralfate and Levothyroxine.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT Fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Fluticasone propionate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone propionate. Drug1 is resolved to Aspirin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone furoate. Drug1 is resolved to Aspirin, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Losartan K+ 25 MG Oral Tablet
Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 979485, name = Losartan Potassium 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Acetylsalicylic acid and Losartan.
Applies to: Lovastatin 40 MG Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = Levothyroxine Sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to Lovastatin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Lovastatin and Levothyroxine.
Applies to: Lovastatin 40 MG Oral Tablet <> Ranitidine 150 MG Oral Tablet
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198191, name = Ranitidine 150 MG Oral Tablet, tty = SCD). Drug1 is resolved to Lovastatin, Drug2 is resolved to Ranitidine and interaction asserted in DrugBank between Lovastatin and Ranitidine.
Applies to: Ranitidine 150 MG Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
Drug1 (rxcui = 198191, name = Ranitidine 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Ranitidine and interaction asserted in DrugBank between Metoprolol and Ranitidine.
Applies to: Lovastatin 40 MG Oral Tablet <> Losartan K+ 25 MG Oral Tablet
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979485, name = Losartan Potassium 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Lovastatin, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Lovastatin and Losartan.
Applies to: aspirin 81 MG Enteric Coated Oral Tablet <> Metoprolol Tartrate 25 MG Oral Tablet
Drug1 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Metoprolol and interaction asserted in DrugBank between Acetylsalicylic acid and Metoprolol.
Applies to: Lovastatin 40 MG Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT Fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to Lovastatin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Lovastatin and Fluticasone furoate. Drug1 is resolved to Lovastatin, Drug2 is resolved to Fluticasone propionate and interaction asserted in DrugBank between Lovastatin and Fluticasone propionate.
Applies to: Metoprolol Tartrate 25 MG Oral Tablet <> Losartan K+ 25 MG Oral Tablet
Drug1 (rxcui = 866924, name = Metoprolol Tartrate 25 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979485, name = Losartan Potassium 25 MG Oral Tablet, tty = SCD). Drug1 is resolved to Metoprolol, Drug2 is resolved to Losartan and interaction asserted in DrugBank between Metoprolol and Losartan.
Applies to: Lovastatin 40 MG Oral Tablet <> aspirin 81 MG Enteric Coated Oral Tablet
Drug1 (rxcui = 197905, name = Lovastatin 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308416, name = Aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to Aspirin, Drug2 is resolved to Lovastatin and interaction asserted in DrugBank between Acetylsalicylic acid and Lovastatin.
Applies to: Methocarbamol 500 MG Oral Tablet <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Drug1 (rxcui = 197943, name = Methocarbamol 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT Fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to Methocarbamol, Drug2 is resolved to Fluticasone propionate and interaction asserted in DrugBank between Methocarbamol and Fluticasone propionate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.